Colette Kirk
Professor Mark Pearce
Professor David Jones
Dr Nicholas Thompson
Emeritus Professor John Mathers
| Health-related quality of life in adults receiving home parenteral nutrition: A multi-centre cross-sectional study | 2026 |
|
Professor David Jones
| Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma | 2026 |
|
Professor David Jones
| Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | 2026 |
|
Professor David Jones
| Long-Term Safety and Efficacy of Obeticholic Acid in Patients With Primary Biliary Cholangitis: Final Results of the POISE Long-Term Safety Extension | 2026 |
|
Dr Jess Dyson
Professor David Jones
Dr George Mells
| Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis | 2026 |
|
Sarah Dunn
Lys Evans
Sam Moody
Dr Faye Wolstenhulme
Dr Emma Burton
et al. | Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid | 2026 |
|
Professor David Jones
Dr Jess Dyson
| The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view | 2026 |
|
Dr George Mells
Professor David Jones
Professor James Wason
Shaun Hiu
Dorcas Kareithi
| COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls | 2025 |
|
Dr Aaron Wetten
Dr Jess Dyson
Professor David Jones
| Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis | 2025 |
|
Dr Aaron Wetten
Dr Jess Dyson
Professor David Jones
| Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? | 2024 |
|
Professor David Jones
| Assessment of fatigue and its impact in chronic liver disease | 2024 |
|
Professor David Jones
Dr George Mells
| Critical shortfalls in the management of PBC: Results of a UK-wide, population-based evaluation of care delivery | 2024 |
|
Dr Aaron Wetten
Dr Jess Dyson
Professor David Jones
| Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis | 2024 |
|
Professor David Jones
| Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis | 2024 |
|
Colette Kirk
Professor John Mathers
Professor Mark Pearce
Dr Nicholas Thompson
Professor David Jones
| Factors that impact on the quality of life of intestinal failure patients treated with home parenteral nutrition: protocol for a multicentre, longitudinal observational study | 2024 |
|
